Lipe & Dalton Sells 200 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Lipe & Dalton lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.7% during the 4th quarter, HoldingsChannel reports. The firm owned 11,913 shares of the company’s stock after selling 200 shares during the period. Lipe & Dalton’s holdings in GE HealthCare Technologies were worth $921,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. Fifth Third Bancorp increased its position in shares of GE HealthCare Technologies by 3.9% during the 4th quarter. Fifth Third Bancorp now owns 33,632 shares of the company’s stock worth $2,600,000 after purchasing an additional 1,250 shares during the last quarter. Douglas Lane & Associates LLC increased its holdings in shares of GE HealthCare Technologies by 22.1% during the 4th quarter. Douglas Lane & Associates LLC now owns 436,253 shares of the company’s stock worth $33,731,000 after acquiring an additional 79,073 shares during the last quarter. Prio Wealth Limited Partnership increased its holdings in shares of GE HealthCare Technologies by 25.1% during the 4th quarter. Prio Wealth Limited Partnership now owns 215,317 shares of the company’s stock worth $16,648,000 after acquiring an additional 43,189 shares during the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of GE HealthCare Technologies by 34.9% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 341,769 shares of the company’s stock worth $23,254,000 after acquiring an additional 88,384 shares during the last quarter. Finally, Federated Hermes Inc. boosted its stake in GE HealthCare Technologies by 90.4% in the 3rd quarter. Federated Hermes Inc. now owns 77,689 shares of the company’s stock valued at $5,286,000 after purchasing an additional 36,886 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC traded down $0.25 on Tuesday, reaching $85.88. The stock had a trading volume of 1,843,246 shares, compared to its average volume of 3,456,091. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The firm has a 50-day moving average of $88.47 and a 200-day moving average of $77.47. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. The company has a market capitalization of $39.19 billion, a price-to-earnings ratio of 28.48, a price-to-earnings-growth ratio of 3.00 and a beta of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. During the same quarter in the prior year, the firm earned $1.31 EPS. The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a dividend of $0.03 per share. The ex-dividend date is Thursday, April 18th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is currently 3.97%.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on GEHC. Evercore ISI boosted their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th. Mizuho boosted their price target on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, April 11th. Argus boosted their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. HSBC started coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They set a “buy” rating and a $100.00 target price for the company. Finally, Morgan Stanley upped their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research report on Monday, February 12th. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average price target of $95.08.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.